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OBJECTIVES: To determine whether hypotensive drugs
may play a pivotal role in inducing orthostatic hypoten-
sion (OH)-related syncope.
DESIGN: Prospective, observational, multicenter study.
SETTING: Acute care wards, syncope units, and centers
for the diagnosis of dementia.
PARTICIPANTS: Individuals aged 65 and older with a
diagnosis of dementia and 1 or more episodes of transient
loss of consciousness of a suspected syncopal nature or
unexplained falls during the previous 3 months
MEASUREMENTS: Blood pressure was measured in the
supine position and in the orthostatic position after 1 and
3 minutes. OH was defined as a decrease in systolic blood
pressure of 20 mmHg or more and in diastolic blood pres-
sure of 10 mmHg or more within 3 minutes of standing.
Univariate and multivariate analyses were used to evaluate
associations between hypotensive drugs and their combi-
nations with OH-related syncope.
RESULTS: The mean age of the study population (n5522;
women, n5324) was 83.566.1, and the most frequent
comorbidity was arterial hypertension (74.5%); 324
(67.8%) participants had had a syncopal fall and 168
(32.2%) a nonsyncopal fall. The mean number of hypo-
tensive drugs administered (2.963.1) did not differ
between the two groups. Syncopal falls was OH-related in
170 participants (48.0%). OH-related syncopal falls were
more frequent in participants receiving nitrates (15.3% vs
9.8%, p5.06), alpha-blockers (16.5% vs 9.8%, p5.04),
or combinations of angiotensin-converting enzyme inhibi-
tors (ACE-Is) and diuretics (20.6% vs 13.0%, p5.04),
alpha-blockers and diuretics (8.2% vs 3.3%, p50.036),
and ACE-Is and nitrates (8.2% vs 3.3%, p5.10). Multi-
variate analysis confirmed a greater risk of OH-related
syncopal fall for nitrates (relative risk (RR)51.77), combi-
nations of ACE-Is and diuretics (RR51.66), and combina-
tions of ACE-Is and nitrates (RR52.32).
CONCLUSION: In older adults with dementia, OH-related
syncopal falls are significantly related to treatment with
nitrates, combinations of ACE-Is and diuretics, and combi-
nations of ACE-Is and nitrates. J Am Geriatr Soc 2018.
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S yncope is defined as a transient loss of consciousness(T-LOC) due to global cerebral hypoperfusion and is
characterized by rapid onset, short duration, and sponta-
neous and complete recovery.1 After the age of 70, the
incidence of syncope increases progressively to approxi-
mately 80 cases per 1,000 individuals per year, with a
prevalence of 10% overall in individuals aged 70 and
older and 23% in institutionalized older adults, who have
a 2-year recurrence rate of 30%.2 The type of syncope dif-
fers substantially between younger and older adults, the
neuromediated form being the most frequent syncope type
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in younger adults and the orthostatic form in older
adults.3
Syncope due to orthostatic hypotension (OH) is one
of the most frequent causes of hospitalization in older peo-
ple. It is difficult to establish the cause of syncope in these
individuals, probably because of their characteristics,
which include a high prevalence of cognitive deficiency.4
In a recent study conducted in a population of older adults
with dementia and recurrent syncope (the Syncope and
Dementia (SYD) Study), syncope due to OH was the most
common type of syncope (50%), and in almost half of
participants, dementia was vascular in origin.5
Arterial hypertension is one of the most common clin-
ical conditions in older adults and is often associated with
the onset of cognitive impairment.6 Appropriate blood
pressure control is a clinical challenge in such individuals
because of the need to counteract the hypotensive effect of
antihypertensive drugs that may result in altered brain per-
fusion.6 In this context, a somewhat paradoxical feature in
older adults with hypertension with cognitive impairment
is the progressive reduction of blood pressure observed in
advanced disease states, probably due to a form of vascu-
lar autonomic dysfunction associated with chronic impair-
ment of brain circulation.6 Consequently, in older adults,
a greater risk of syncope and falls may follow initially
effective treatment of arterial hypertension because of the
onset of OH, which is often underestimated.7 We investi-
gated whether hypotensive drugs could be related to the
prevalence of OH syncope in older adults with dementia
and recurring syncope enrolled in the SYD study.5
METHODS
The SYD study, which the Gruppo Italiano per lo Studio
della Sincope (Italian Group for the Study of Syncope)
designed with the endorsement of the Italian Society of
Gerontology and Geriatrics, was conducted in 9 geriatric
departments of academic and nonacademic Italian hospi-
tals.8 Briefly, the SYD study enrolled individuals aged 65
and older with a diagnosis of dementia (according to the
criteria of the Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, Text Revision), and one or
more episodes of T-LOC of a suspected syncopal nature
or an unexplained fall during the previous 3 months.
Participants were nursing home or acute care unit res-
idents and outpatients attending syncope units, units for
Alzheimer diagnosis, and day hospitals. The only exclu-
sion criterion was unwillingness or inability of the individ-
ual or his or her legal caregiver to provide informed
consent.
Clinical characteristics were evaluated using standar-
dized assessment tools. Information on pharmacological
treatment before the T-LOC or fall was also collected.
Functional status, expressed as the number of lost activ-
ities of daily living (ADLs) or instrumental activities of
daily living (IADLs) 1 month before the T-LOC or fall,
was assessed through individual and proxy interviews.
Cognitive function was investigated using the Mini-Mental
State Examination (MMSE) and depressive symptoms
using the Geriatric Depression Scale. The latter was used
only in individuals with a MMSE score greater than 16.
Comorbidity was assessed using the Cumulative Illness
Rating Scale (CIRS). Syncope was defined as a T-LOC
attributed to transient global cerebral hypoperfusion if it
was of rapid onset and short duration and was character-
ized by spontaneous, complete recovery.1 An unexplained
fall was defined as a clearly nonaccidental fall not related
to a precise medical or drug-induced cause and without
any apparent cause.9
Diagnostic Protocol
All participants were evaluated according to the European
Society of Cardiology syncope guidelines1. All underwent
the initial evaluation, which consists of detailed, specific
history-taking (collected with the assistance of proxy
information) and physical examination.1 Blood pressure
was measured with the participant in the supine position
and then in the orthostatic position after 1 and 3 minutes.
Accordingly, OH was measured during the diagnostic pro-
tocol within a maximum 72 hours after the last episode
and defined as a decrease of 20 mmHg or more in systolic
blood pressure and 10 mmHg or more in diastolic blood
pressure within 3 minutes of standing. All participants
underwent electrocardiography and carotid sinus massage
in the supine position with electrocardiographic monitor-
ing (when not contraindicated).1 A second-level neuroau-
tonomic, neurological, or cardiological (when needed
according to European Society of Cardiology guidelines)
evaluation was undertaken in participants in whom a reli-
able diagnosis could not be established from the initial
evaluation.8 At the end of the diagnostic protocol, partici-
pants were divided into 2 groups: syncopal falls and non-
syncopal falls. Nonsyncopal falls included unexplained
falls, falls without loss of consciousness (e.g., drop attacks,
psychiatric disorders), and falls with nonsyncopal loss of
consciousness (e.g., epilepsy, stroke, other metabolic
disturbances).
A syncopal fall was attributed to OH after other pos-
sible causes of syncope were excluded or in case of a posi-
tive OH test, a positive head-up tilt test, predisposing
factors, precipitating factors, or a history of OH.
Ethics
The Research Ethics Committee of the University of
Naples Federico II School of Medicine, and the institu-
tional review boards of all participating centers approved
the study.
Statistical Analysis
The baseline characteristics of the sample are expressed as
means6standard deviations. Participants were stratified
based on hypotensive drugs taken and presence or absence
of syncope due to OH. Univariate and multivariate analy-
ses were performed using binary logistic regression; hypo-
tensive drugs (alone or in combination) that significantly
affected the presence of OH-related syncope were consid-
ered dependent variables, and age, sex, prodromes, num-
ber of hypotensive drugs, comorbidity (CIRS severity),
presence of a pacemaker, and lost ADLs (disability) were
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considered confounding variables. All statistical analyses
were performed using SPSS version 15.0 (SPSS Inc., Chi-
cago, IL). P<.05 was considered statistically significant.
RESULTS
The clinical features of the 522 participants are reported in
Table 1. The mean age of our study population was
83.566.1, and 60% were female. Participants had a mean
362 ADLs and 662 IADLs lost, and the average MMSE
score was 16.765.5. Subjects were stratified according to
syncopal (n5354, 67.8%) and nonsyncopal (n5168,
32.2%) falls. CIRS severity score was significantly higher in
participants with nonsyncopal falls (1.660.3) than in those
with syncopal falls (1.760.4) (p5.02). Vascular dementia
was the most frequent form of dementia (41.6%) followed
by Alzheimer’s disease (33%) and mixed dementia (15.5%),
with no significant difference between participants with syn-
copal and nonsyncopal falls. The most frequent comorbidity
was arterial hypertension (74.5%), followed by psychiatric
disease (32.2%), carotid atherosclerosis (25.1%), atrial
fibrillation (24.7%), and type II diabetes mellitus (22.0%).
Participants with nonsyncopal falls were more likely to have
a history of stroke (11.6%) than those with syncopal falls
(19.6%) (p5.01), whereas the prevalence of transient ische-
mic attacks did not differ significantly between the two
groups. The presence of prodromes differed significantly
between participants with syncopal and non-syncopal falls
(Table 1).
Syncope with fall due to OH was the most frequent
type of syncope (n5170, 48.0%) followed by neuromedi-
ated syncope (n5102, 28.8%), cardiac syncope (n545,
12.7%), and syncope of unknown origin (n537, 10.5%).
Syncopal falls were attributed to OH in the case of a posi-
tive OH test (n5112/170, 65.9%), a positive head-up tilt
test (n59/170, 5.3%), predisposing factors (n520/170,
11.8%), precipitating factors (n5 19/170, 11.2%), or a
history of OH (n510/170, 5.9%).
Clinical features of participants with syncopal falls
stratified according to presence of syncope due to OH did
not differ significantly between the 2 groups, although the
incidence of stroke was higher in participants without
than in those with syncope due to OH (Table 2). All par-
ticipants with an implanted pacemaker enrolled in the
study were in the group without syncope due to OH (20
vs 0, p<.001). The presence of prodromes differed
Table 1. Baseline Participant Characteristics
Characteristic Total, N 5 522
Syncopal Fall,
n 5 354 (67.8%)
Nonsyncopal Fall,
n 5 168 (32.2%) P-Value
Age, mean 6 SD 83.5 6 6.1 83.3 6 6.4 83.9 6 5.7 .24
Female, n (%) 324 (62.1) 218 (61.6) 106 (63.1) .41
Systolic blood pressure, mmHg, mean 6 SD 130.0 6 18.8 130.6 6 20.0 129.8 6 18.4 .71
Diastolic blood pressure, mmHg, mean 6 SD 80.4 6 12.8 81.2 6 11.4 78.2 6 10.5 .13
Prodromes, n (%) 180 (34.5) 143 (40.4) 37 (22.0) <.001
Cumulative Illness Rating Scale score, mean 6 SD 1.6 6 0.4 1.6 6 0.3 1.7 6 0.4 .02
Lost activities of daily living, mean 6 SD 3 6 2 3 6 2 3 6 2 .17
Lost instrumental activities of daily living, mean 6 SD 6 6 2 6 6 2 6 6 2 .90
Mini-Mental State Examination score, mean 6 SD 16.7 6 5.5 16.9 6 5.4 16.2 6 5.7 .16
Geriatric Depression Scale score, mean 6 SD 5.6 6 3.4 5.5 6 3.4 5.6 6 3.4 .95
Number of hypotensive drugs, mean 6 SD 2.7 6 3.0 2.9 6 3.1 2.5 6 2.7 .18
Taking <2 hypotensive drugs n (%) 255 (48.9) 177 (50.0) 78 (56.4) .45
Type of dementia, n (%)
Alzheimer’s 172 (33.0) 113 (31.9) 59 (35.1) .26
Vascular 217 (41.6) 152 (42.9) 65 (38.7) .20
Mixed 81 (15.5) 55 (15.5) 26 (15.5) .55
Parkinson’s 31 (5.9) 20 (5.6) 11 (6.5) .41
Lewy bodies 10 (2.0) 7 (2.0) 3 (1.8) .59
Frontotemporal 5 (1.0) 3 (0.8) 2 (1.2) .52
Normal pressure hydrocephalus 5 (1.0) 3 (0.8) 2 (1.2) .52
Alcoholic 1 (0.2) 1 (0.3) 0 (0.0) .88
Comorbidities, n (%)
Arterial hypertension 389 (74.5) 263 (74.3) 126 (75.0) .48
Coronary artery disease 100 (19.2) 69 (19.5) 31 (18.5) .44
Chronic heart failure 47 (9.0) 30 (8.5) 17 (10.1) .32
Atrial fibrillation 129 (24.7) 89 (25.1) 40 (23.8) .41
Stroke 74 (14.2) 41 (11.6) 33 (19.6) .01
Transient ischemic attack 39 (7.5) 27 (7.6) 12 (7.1) .50
Carotid atherosclerosis 131 (25.1) 97 (27.4) 34 (20.2) .08
Epilepsy 20 (3.8) 12 (3.4) 8 (4.8) .30
Psychiatric disease 168 (32.2) 119 (33.6) 49 (29.2) .18
Type 2 diabetes mellitus 115 (22.0) 74 (20.9) 41 (24.4) .21
Dysthyroidism 57 (10.9) 34 (10.9) 23 (10.9) .16
Pacemaker 20 (3.8) 20 (3.8) 0 (0.0) <.001
SD 5 standard deviation.
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significantly between participants with and without OH-
related syncope (p5.02) (Table 2).
In the whole sample and in participants with syncopal
and nonsyncopal falls, diuretics were the most frequently
prescribed hypotensive drugs (37.9%), followed by
angiotensin-converting enzyme inhibitors (ACE-Is)
(33.7%), beta-blockers (26.8%), angiotensin II type 1
receptor blockers (17.8%), calcium antagonists (18.4%),
Table 2. Baseline Participant Characteristics Stratified According to Presence of Syncope Due to Orthostatic Hypo-
tension (OH)
Characteristic
Syncopal Fall Due to OH
P-ValueYes, n 5 170 (48.0%) No, n 5 184 (52.0%)
Age, mean 6 SD 83.5 6 6.1 83.3 6 6.1 .24
Female, n (%) 96 (56.5) 228 (64.8) .04
Systolic blood pressure, mmHg, mean 6 SD 129.2 6 19.1 130.5 6 18.7 .49
Diastolic blood pressure, mmHg, mean 6 SD 76.2 6 11.4 81.6 6 10.5 .26
Number of syncope episodes, mean 6 SD 3.6 6 3.3 3.3 6 2.8 .37
Prodromes, n (%) 70 (41.2) 110 (31.3) .02
Cumulative Illness Rating Scale score, mean 6 SD 1.6 6 0.4 1.6 6 0.4 .79
Lost activities of daily living, mean 6 SD 2 6 2 3 6 2 .10
Lost instrumental activities of daily living, mean 6 SD 6 6 2 6 6 2 .63
Mini-Mental State Examination score, mean 6 SD 17.7 6 4.9 16.2 6 5.7 .005
Geriatric Depression Scale score, mean 6 SD 5.7 6 3.5 5.4 6 3.3 .42
Number of hypotensive drugs, mean 6 SD 3.1 6 3.2 2.7 6 3.0 .18
Taking <2 hypotensive drugs n (%) 93 (52.5) 84 (47.5) .11
Type of dementia, n (%)
Alzheimer’s 56 (32.9) 116 (33.0) .54
Vascular 74 (43.5) 143 (40.6) .29
Mixed 19 (11.2) 62 (17.6) .04
Parkinson’s 14 (8.2) 17 (4.8) .09
Lewy bodies 4 (2.4) 6 (1.7) .42
Frontotemporal 1 (0.6) 4 (1.8) .48
Normal pressure hydrocephalus 1 (0.6) 4 (1.1) .48
Alcoholic 1 (0.6) 0 (0.0) .33
Comorbidities, n (%)
Arterial hypertension 131 (77.1) 258 (73.3) .21
Coronary artery disease 36 (21.2) 64 (18.2) .24
Chronic heart failure 18 (10.6) 29 (8.2) .23
Atrial fibrillation 40 (23.5) 89 (25.3) .41
Stroke 18 (10.6) 56 (15.9) .06
Transient ischemic attack 10 (5.9) 29 (8.2) .22
Carotid atherosclerosis 44 (25.9) 97 (24.7) .43
Epilepsy 7 (4.1) 13 (3.7) .49
Psychiatric disease 62 (36.5) 106 (30.1) .09
Type 2 diabetes mellitus 39 (22.9) 76 (21.6) .40
Dysthyroidism 16 (9.4) 41 (22.2) .24
Pacemaker 0 (0.0) 20 (5.7) <.001
SD 5 standard deviation.
Table 3. Univariate and Multivariate Analysis of Effect of Hypotensive Drugs Alone or in Combination on Risk of
Syncope Due to Orthostatic Hypotension in Older Adults with Dementia
Multivariate
Univariate Age and Sex 1 Prodromes 1 Number of Drugs 1 Comorbidity 1 Pacemaker 1 Disability
Drug or
Combinations Relative Risk (95% Confidence Interval)
Alpha-blocker 1.67 (1.00–2.85) 1.48 (0.84–2.60) 1.56 (0.88–2.76) 1.36 (0.74–2.51) 1.31 (0.70–2.42) 1.30 (0.69–2.43) 1.26 (0.67–2.37)
Nitrate 1.74 (1.00–3.20) 1.85 (1.05–3.25) 1.77 (1.01–3.12) 1.55 (1.00–3.24) 1.62 (0.84–3.12) 1.79 (0.91–3.53) 1.85 (0.93–3.67)
Alpha-blocker
1 diuretic
2.01 (1.00–4.28) 1.83 (0.85–3.96) 1.89 (0.87–4.11) 1.58 (0.68–3.63) 1.54 (0.67–3.55) 1.60 (0.67–3.79) 1.52 (0.64–3.61)
ACE-I 1 diuretic 1.70 (1.04–2.78) 1.69 (1.03–2.76) 1.66 (1.01–2.72) 1.48 (0.83–2.63) 1.43 (0.79–2.58) 1.37 (0.76–2.47) 1.40 (0.80–2.53)
ACE-I 1 nitrate 2.34 (1.07–5.09) 2.43 (1.11–5.34) 2.32 (1.05–5.12) 1.98 (0.83–4.68) 1.96 (0.82–4.64) 1.96 (0.81–4.72) 2.01 (0.82–4.87)
ACE-I 5 angiotensin-converting enzyme inhibitor.
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nitrates (11.3%), and alpha-blockers (12.5%). There were
no significant differences in the prevalence of hypotensive
drugs between participants with and without syncopal
falls.
When participants with dementia and syncopal falls
were stratified according to OH-related syncope and non-
OH-related syncope, the prevalence of nitrates (15.3% vs
9.8%) and alpha-blockers (16.5% vs 9.8%) (Figure 1) and
the combinations of ACE-Is and diuretics (20.6% vs 13.0%),
alpha-blockers and diuretics (8.2% vs 3.3%), and of ACE-Is
and nitrates (8.2% vs 3.3%) (Figure 2) were significantly
more prevalent in participants with OH-related syncope.
Upon multivariate analysis, only the effect of nitrates
on syncope due to OH was partially confirmed, maintain-
ing its significance after adjustment for age, sex, pro-
dromes, and number of hypotensive drugs. The relative
risk of syncope due to OH was significant in participants
treated with alpha-blockers and diuretics, ACE-Is and diu-
retics, and ACE-Is and nitrates. Multivariate analysis con-
firmed that the presence of a pacemaker and disability
increased the relative risk in participants receiving ACE-Is
and diuretics or ACE-Is and nitrates only when corrected
for age, sex, and prodromes (see Table 3).
DISCUSSION
In older adults with dementia, nitrates and alpha-blockers
alone and the combinations of ACE-Is and diuretics, alpha-
blockers and diuretics, and ACE-Is and nitrates are more fre-
quent in patients with than in those without syncope due to
OH. Multivariate analyses, adjusted for age and sex, pro-
dromes, number of hypotensive drugs, comorbidity, the pres-
ence of a pacemaker, and disability, revealed a significant
risk of syncope due to OH in participants treated with
nitrates alone and in those treated with the combination of
ACE-I’s and diuretics or ACE-inhibitors and nitrates.
Syncope Due to OH in Older Adults with Dementia
Syncope is one of the most important clinical problems in
individuals aged 70 and older.2,3,8 In our sample, syncope
due to OH was by far the most prevalent (50%) form of
syncope, followed by neuromediated (30%), cardiac
(10%), and unexplained (10%) syncope. Syncope due to
OH is one of the more severe clinical manifestations of OH,
and the prevalence of OH increases progressively with
age,7,10–12 but data on the prevalence of syncope due to OH
are unclear. Comorbidities, hypertension, and diabetes have
been implicated in these discordant observations,6,13–15 and
although the prevalence of OH is high in older people with-
out dementia, it is not always reported as one of the main
causes of syncope. In the SYD study, conducted exclusively
in older adults with dementia, syncope due to OH was
more frequent than the other types of syncope, but the rea-
son is unknown.4,5,16 Baroreceptor dysfunction at the onset
of OH is closely related to aging and to the effects of hyper-
tension and, consequently, to arterial stiffness.13–15,17,18
Hypotensive Drugs and OH in Older Adults with
Dementia
Arterial hypertension and its consequences (coronary
artery disease, atrial fibrillation, chronic heart failure) are
among the most common clinical conditions in older
adults and are frequently treated with hypotensive
drugs.6,17 Most individuals with syncope and dementia in
our sample had one or more of these conditions, so hypo-
tensive agents were the most frequently used drugs. In par-
ticular, the higher prevalence of syncope due to OH was
associated with nitrates and alpha-blockers alone and with
combinations of ACE-Is and diuretics and of ACE-Is and
nitrates. The relationship between treatment with hypoten-
sive drugs and syncope due to OH has been widely stud-
ied.19 Aggressive blood pressure treatment has been
related to OH, although the role of specific drugs and
combinations is unclear.19 In a recent study conducted in
172 older adults with dementia and mild cognitive impair-
ment treated with antihypertensive drugs, participants
with systolic pressure of 128 mmHg or less had a greater
reduction of the MMSE scores (–2.8) than those with sys-
tolic pressure between 129 and 144 mmHg and 145
mmHg and higher (–0.7), which indicates that low blood
pressure is associated with greater cognitive decline.20
Thus, aggressive hypotensive therapy seems to exacerbate
negative relationship among low blood pressure, dementia,
and syncope due to OH.19
Figure 1. Prevalence of hypotensive drugs administered to
participants with and without syncopal falls.
Figure 2. Prevalence of combinations of hypotensive drugs
administered to participants with and without syncopal falls.
ACE-Is 5 angiotensin-converting enzyme inhibitors.
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Hypotensive Drugs, OH, and Cognitive Decline: A
Dangerous Relationship
The relationship between OH and cognitive decline has
been attributed to a common pathological process that
affects areas involved in cognition and autonomic cardi-
ovascular control.21,22 The cerebral areas involved in
the neurodegenerative process may include areas that
govern the autonomic control of the cardiovascular sys-
tem, so neurodegeneration may be responsible for cogni-
tive deficiency and OH.20 Alternatively, OH may cause
a state of cerebral hypoperfusion. In this context, fron-
tal lobe hypoperfusion has been described in individuals
with OH and reported to lead to altered executive
functions.21–23
Antihypertensive therapy was found to be significantly
associated with OH in the Rotterdam Study24 and in the
Malmoe Preventive Project.25 In the British Women’s
Heart and Health Study of 4,286 women aged 60 to 80,
number of hypotensive drugs was significantly associated
with prevalence of OH.26 A retrospective study of 75-
year-old individuals found that the number of causative
drugs (alpha blockers, antihypertensive agents, diuretics)
was positively correlated with the prevalence of OH, with
an increase ranging from 35% to 65% as the number of
hypotensive drugs taken increased.27
CONCLUSIONS
The number of drugs administered, and in particular spe-
cific hypotensive drugs used alone or in combination,
strongly influence syncope due to OH. Such drugs,
namely, nitrates alone and combinations of ACE-Is and
diuretics and of ACE-Is and nitrates significantly increase
the risk of syncope due to OH and should be used with
extreme caution in older adults with dementia.
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